Company intelligence / Profile preview

MediCool Technologies

Traverse City, Michigan, United Statesmedicooltech.com ↗

Ownership: Private
Employees: ~6
Development stage: Preclinical

Overview

MediCool Technologies has developed a novel, painless device-based approach to terminate dangerous cardiac arrhythmias such as atrial fibrillation using "cool cardioversion." The company has completed significant early clinical work and built a tested prototype. Their solution addresses an unmet need in the large market of patients with irregular heart rhythms by offering an alternative to painful electrical shocks currently used in standard defibrillation.

Therapeutic areas: Cardiovascular
Modalities: Device (specifically, implantable and external devices for cardiac arrhythmia therapy)
Industry: Therapeutic Medical Devices

Partnerships

Mayo Clinic (spinoff origin)

Beyond the preview

Go deeper on MediCool Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MediCool Technologies.

Explore the full profile